Malaysian Society of Gastroenterology and Hepatology

The Malaysian Society of Gastroenterology and Herpetology, organized by the Allergy and Immunology Academies of Malaysia. The working party of societies statements aim to provide evidence and guidelines to practising doctors on the use of antiplatelet therapy and proton pump inhibitors (PPIs) in patients with cardiovascular risk as well as those at risk of gastrointestinal bleeding. Balancing the GI and cardiovascular risk and benefits of antiplatelet therapy and PPIs may sometimes pose a significant challenge to doctors. So Malaysian Society Of Gastroenterology and Hepatology society mainly useful for patients having issue with health with gastroenterology and this society is responsible for Concomitant use of anti-secretory medications, which reduce the risk of GI bleeding but concerns raised on the potential interaction of PPIs and clopidogrel. Many new data have emerged on this society but some can be confusing and at times controversial. These statements examined the supporting evidence in four main areas: rationale for antiplatelet therapy, risk factors of GI bleeding, PPI-clopidogrel interactions and timing for recommencing antiplatelet therapy after GI bleeding. This society rapidly growing day by day to cure and meet gastroenterologist’s patients.